交易 VBI Vaccines Inc. - VBIV CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
VBI Vaccines Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 16, 2024 | 0.60 | 0.06 | 11.11% | 0.54 | 0.61 | 0.53 |
Apr 15, 2024 | 0.54 | 0.00 | 0.00% | 0.54 | 0.54 | 0.53 |
Apr 12, 2024 | 0.55 | -0.02 | -3.51% | 0.57 | 0.58 | 0.53 |
Apr 11, 2024 | 0.57 | -0.01 | -1.72% | 0.58 | 0.58 | 0.53 |
Apr 10, 2024 | 0.61 | -0.09 | -12.86% | 0.70 | 0.70 | 0.56 |
Apr 9, 2024 | 0.63 | -0.28 | -30.77% | 0.91 | 1.31 | 0.63 |
Apr 8, 2024 | 0.90 | 0.21 | 30.43% | 0.69 | 0.95 | 0.68 |
Apr 5, 2024 | 0.69 | 0.04 | 6.15% | 0.65 | 0.69 | 0.62 |
Apr 4, 2024 | 0.64 | -0.07 | -9.86% | 0.71 | 0.74 | 0.63 |
Apr 3, 2024 | 0.73 | 0.05 | 7.35% | 0.68 | 0.74 | 0.64 |
Apr 2, 2024 | 0.67 | 0.06 | 9.84% | 0.61 | 0.70 | 0.57 |
Apr 1, 2024 | 0.60 | 0.03 | 5.26% | 0.57 | 0.61 | 0.57 |
Mar 28, 2024 | 0.58 | 0.01 | 1.75% | 0.57 | 0.59 | 0.57 |
Mar 27, 2024 | 0.55 | 0.01 | 1.85% | 0.54 | 0.56 | 0.54 |
Mar 26, 2024 | 0.56 | 0.00 | 0.00% | 0.56 | 0.56 | 0.55 |
Mar 25, 2024 | 0.54 | -0.02 | -3.57% | 0.56 | 0.56 | 0.54 |
Mar 22, 2024 | 0.54 | 0.00 | 0.00% | 0.54 | 0.56 | 0.54 |
Mar 21, 2024 | 0.54 | -0.02 | -3.57% | 0.56 | 0.56 | 0.53 |
Mar 20, 2024 | 0.56 | 0.00 | 0.00% | 0.56 | 0.57 | 0.55 |
Mar 19, 2024 | 0.56 | 0.01 | 1.82% | 0.55 | 0.56 | 0.55 |
VBI Vaccines Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 13, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 VBI Vaccines Inc Earnings Release Q1 2024 VBI Vaccines Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 21, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 VBI Vaccines Inc Annual Shareholders Meeting VBI Vaccines Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, June 25, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 VBI Vaccines Inc Annual Shareholders Meeting VBI Vaccines Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Monday, August 12, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 VBI Vaccines Inc Earnings Release Q2 2024 VBI Vaccines Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.082 | 0.631 | 1.061 | 2.221 | 3.355 |
收入 | 1.082 | 0.631 | 1.061 | 2.221 | 3.355 |
收入成本,共計 | 11.276 | 10.77 | 9.168 | 7.904 | 4.509 |
毛利 | -10.194 | -10.139 | -8.107 | -5.683 | -1.154 |
總營業費用 | 83.074 | 68.663 | 44.678 | 54.62 | 63.763 |
銷售/一般/行政費用,總計 | 56.12 | 38.335 | 20.651 | 14.092 | 14.509 |
研究與開發 | 15.506 | 19.558 | 14.859 | 26.332 | 38.443 |
營業收入 | -81.992 | -68.032 | -43.617 | -52.399 | -60.408 |
利息收入(費用),非經營淨值 | -31.311 | -1.721 | -2.613 | -2.414 | -3.192 |
稅前淨收入 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
稅後淨收入 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
未計算非常項目前的淨收益 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
淨收入 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
普通股股東可獲收益 (不含非經常性項目) | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
普通股股東可獲收益 (含非經常性項目) | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
攤薄淨收入 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
攤薄後加權平均股 | 8.60858 | 8.49739 | 7.27491 | 3.98115 | 2.18804 |
扣除特別項目的每股攤薄盈利 | -13.1616 | -8.20876 | -6.35472 | -13.7681 | -29.0671 |
每股正常攤薄盈利 | -13.1417 | -8.20876 | -6.35472 | -12.1877 | -26.1869 |
異常費用(收入) | 0.172 | 0 | 6.292 | 6.302 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.72 | 0.485 | 0.293 | 0.317 | 0.346 |
收入 | 0.72 | 0.485 | 0.293 | 0.317 | 0.346 |
收入成本,共計 | 3.483 | 3.559 | 3.328 | 2.672 | 2.522 |
毛利 | -2.763 | -3.074 | -3.035 | -2.355 | -2.176 |
總營業費用 | 37.692 | 19.994 | 21.732 | 22.047 | 23.249 |
銷售/一般/行政費用,總計 | 10.917 | 13.284 | 15.886 | 14.22 | 15.084 |
研究與開發 | 3.292 | 3.151 | 2.518 | 4.983 | 5.643 |
營業收入 | -36.972 | -19.509 | -21.439 | -21.73 | -22.903 |
利息收入(費用),非經營淨值 | -7.656 | -8.242 | 0.298 | -3.479 | -22.796 |
稅前淨收入 | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
稅後淨收入 | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
未計算非常項目前的淨收益 | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
淨收入 | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
普通股股東可獲收益 (不含非經常性項目) | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
普通股股東可獲收益 (含非經常性項目) | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
攤薄淨收入 | -44.628 | -27.751 | -21.141 | -25.209 | -45.699 |
攤薄後加權平均股 | 8.60854 | 8.60854 | 8.60858 | 8.60772 | 8.60772 |
扣除特別項目的每股攤薄盈利 | -5.18415 | -3.22366 | -2.4558 | -2.92865 | -5.30907 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -2.86088 | -3.22366 | -2.4558 | -2.90867 | -5.30907 |
異常費用(收入) | 20 | 0 | 0.172 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 77.69 | 130.284 | 132.041 | 46.963 | 61.731 |
現金和短期投資 | 62.629 | 121.694 | 119.101 | 44.213 | 59.27 |
現金 | 62.629 | 121.694 | 93.825 | 44.213 | 59.27 |
應收賬款總額,淨額 | 4.127 | 1.446 | 0.077 | 0.201 | 0.056 |
應收賬款 - 貿易,淨額 | 0.094 | 0.008 | 0.077 | 0.201 | 0.056 |
總庫存 | 6.599 | 2.576 | 2.152 | 1.075 | 0.911 |
其他流動資産,總計 | 2.026 | 2.195 | 9.142 | 0.45 | 0.512 |
總資産 | 155.086 | 210.276 | 209.372 | 122.201 | 137.605 |
物業/廠房/設備,總計 - 淨額 | 15.569 | 14.381 | 12.275 | 11.654 | 8.525 |
物業/廠房/設備,總計 - 總額 | 23.55 | 19.34 | 15.885 | 14.414 | 10.936 |
累計折舊,總計 | -7.981 | -4.959 | -3.61 | -2.76 | -2.411 |
商譽,淨額 | 2.127 | 2.261 | 2.261 | 2.208 | 8.265 |
無形資産,淨額 | 58.345 | 62.091 | 62.156 | 60.756 | 58.249 |
長期投資 | |||||
其他長期資産,總計 | 1.355 | 1.259 | 0.639 | 0.62 | 0.835 |
流動負債總額 | 36.942 | 32.586 | 17.348 | 29.757 | 23.377 |
應付賬款 | 12.973 | 4.28 | 3.734 | 1.127 | 6.055 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 9.15 | 12.172 | 1.437 | 1.712 | 4.165 |
負債總額 | 90.923 | 66.394 | 37.667 | 33.946 | 39.472 |
長期債務總額 | 48.888 | 28.441 | 16.329 | 0 | 12.927 |
長期債務 | 48.888 | 28.441 | 16.329 | 0 | 12.927 |
遞延所得稅 | |||||
其他負債,總計 | 5.093 | 5.367 | 3.99 | 4.189 | 3.168 |
股權 | 64.163 | 143.882 | 171.705 | 88.255 | 98.133 |
普通股 | 442.312 | 442.235 | 403.528 | 284.965 | 246.417 |
額外實收資本 | 90.02 | 81.583 | 75.53 | 66.43 | 63.449 |
留存收益(累計赤字) | -489.609 | -378.371 | -308.618 | -262.388 | -207.575 |
其他權益,總計 | 21.44 | -1.565 | 1.265 | -0.752 | -4.158 |
總負債和股東權益 | 155.086 | 210.276 | 209.372 | 122.201 | 137.605 |
已發行普通股總數 | 8.60772 | 8.60748 | 8.23381 | 5.94131 | 3.24447 |
預付的費用 | 2.309 | 2.373 | 1.569 | 1.024 | 0.982 |
預提費用 | 14.819 | 16.134 | 12.177 | 12.073 | 12.057 |
長期債務的當前部分/資本租賃 | 0 | 14.845 | 1.1 | ||
短期投資 | 0 | 25.276 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 50.147 | 31.891 | 51.836 | 77.69 | 96.216 |
現金和短期投資 | 35.454 | 20.84 | 40.392 | 62.629 | 83.55 |
現金 | 35.454 | 20.84 | 40.392 | 62.629 | 83.55 |
短期投資 | |||||
應收賬款總額,淨額 | 3.823 | 1.657 | 1.484 | 4.127 | 2.482 |
應收賬款 - 貿易,淨額 | 0.353 | 0.079 | 0.281 | 0.094 | 0.132 |
總庫存 | 7.54 | 6.861 | 6.768 | 6.599 | 5.796 |
預付的費用 | 2.93 | 1.667 | 2.419 | 2.309 | 2.73 |
其他流動資産,總計 | 0.4 | 0.866 | 0.773 | 2.026 | 1.658 |
總資産 | 100.784 | 88.322 | 128.461 | 155.086 | 172.01 |
物業/廠房/設備,總計 - 淨額 | 11.819 | 12.807 | 14.682 | 15.569 | 14.614 |
商譽,淨額 | 2.121 | 2.175 | 2.132 | 2.127 | 2.104 |
無形資産,淨額 | 35.603 | 40.339 | 58.5 | 58.345 | 57.727 |
其他長期資産,總計 | 1.094 | 1.11 | 1.311 | 1.355 | 1.349 |
流動負債總額 | 77.194 | 27.674 | 29.573 | 36.942 | 34.681 |
應付賬款 | 7.008 | 7.353 | 9.837 | 12.973 | 11.666 |
預提費用 | 7.85 | 10.906 | 12.182 | 14.819 | 13.5 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 12.037 | 7.425 | 7.554 | 9.15 | 9.515 |
負債總額 | 80.898 | 79.584 | 83.439 | 90.923 | 88.193 |
長期債務總額 | 0 | 47.839 | 49.359 | 48.888 | 48.418 |
長期債務 | 0 | 47.839 | 49.359 | 48.888 | 48.418 |
其他負債,總計 | 3.704 | 4.071 | 4.507 | 5.093 | 5.094 |
股權 | 19.886 | 8.738 | 45.022 | 64.163 | 83.817 |
普通股 | 453.901 | 442.322 | 442.322 | 442.312 | 442.3 |
額外實收資本 | 105.955 | 93.695 | 92.021 | 90.02 | 87.705 |
留存收益(累計赤字) | -582.432 | -561.988 | -517.36 | -489.609 | -468.468 |
其他權益,總計 | 42.462 | 34.709 | 28.039 | 21.44 | 22.28 |
總負債和股東權益 | 100.784 | 88.322 | 128.461 | 155.086 | 172.01 |
已發行普通股總數 | 23.3392 | 8.60854 | 8.60854 | 8.60772 | 8.60772 |
長期債務的當前部分/資本租賃 | 50.299 | 1.99 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 |
經營活動産生的現金 | -73.695 | -39.908 | -47.05 | -48.712 | -45.533 |
經營活動産生的現金 | 2.061 | 1.835 | 1.652 | 1.204 | 0.542 |
Deferred Taxes | 0 | ||||
非現金物品 | 40.208 | 12.801 | 7.666 | 11.525 | 5.053 |
已付現金利息 | 3.231 | 2.039 | 1.608 | 2.033 | 1.98 |
營運資金的變化 | -2.661 | 15.209 | -10.138 | -6.628 | 12.472 |
投資活動産生的現金 | -4.344 | 23.156 | -26 | -3.673 | -5.993 |
資本支出 | -4.344 | -1.995 | -1 | -3.673 | -5.993 |
其他投資現金流量項目,總計 | 0 | 25.151 | -25 | 0 | |
融資活動産生的現金 | 19.449 | 44.293 | 122.392 | 37.415 | 43.617 |
股票的發行(報廢),淨額 | 0.012 | 33.382 | 124.325 | 40.25 | 46.623 |
債務的發行(退還),淨額 | 20 | 12 | 4.7 | ||
外彙效應 | -0.475 | 0.328 | 0.27 | -0.087 | -0.515 |
現金淨變化 | -59.065 | 27.869 | 49.612 | -15.057 | -8.424 |
融資現金流項目 | -0.563 | -1.089 | -6.633 | -2.835 | -3.006 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -27.751 | -113.303 | -92.162 | -66.953 | -21.254 |
Cash From Operating Activities | -21.656 | -73.695 | -54.649 | -37.375 | -19.925 |
Cash From Operating Activities | 0.508 | 2.061 | 1.541 | 1.015 | 0.473 |
Non-Cash Items | 9.639 | 40.208 | 38.591 | 32.47 | 7.429 |
Cash Interest Paid | 1.437 | 3.231 | 2.067 | 1.248 | 0.604 |
Changes in Working Capital | -4.052 | -2.661 | -2.619 | -3.907 | -6.573 |
Cash From Investing Activities | -0.534 | -4.344 | -2.892 | -1.592 | -0.515 |
Capital Expenditures | -0.534 | -4.344 | -2.892 | -1.592 | -0.515 |
Cash From Financing Activities | 0 | 19.449 | 19.449 | 0.012 | 0.012 |
Financing Cash Flow Items | -0.563 | -0.563 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0 | 0.012 | 0.012 | 0.012 | 0.012 |
Issuance (Retirement) of Debt, Net | 0 | 20 | 20 | 0 | |
Foreign Exchange Effects | -0.047 | -0.475 | -0.052 | -0.325 | 0.071 |
Net Change in Cash | -22.237 | -59.065 | -38.144 | -39.28 | -20.357 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
160 Second Street
Cambridge
CAMBRIDGE
MASSACHUSETTS 02142
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易